Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01943903 · ClinicalTrials.gov registry record
The PLATFORM Study: Prospective LongitudinAl Trial of FFRct: Outcome and Resource IMpacts)
A clinical trial, sponsored by HeartFlow.
- Completed
- Registry status
- 584
- Enrollment target
NCT01943903 is a clinical trial that has completed, run by HeartFlow. The registered enrollment target is 584 participants.
The verdict
NCT01943903 has completed, sponsored by HeartFlow.
- COMPLETED
- Registry status
- 584 participants
- Enrollment target
Study Summary
The objective of the PLATFORM Study is to compare clinical outcomes, resource utilization, and quality of life (QOL) of FFRCT-guided evaluation versus standard practice evaluation in patients with suspected CAD in order to further inform patients, health care providers, and other stakeholders about which technologies are most effective and efficient in the diagnosis of CAD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 584 participants |
| Start Date | 2013-09 |
| Est. Completion | 2015-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01943903
The ClinicalTrials.gov registry entry for NCT01943903 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 584 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is HeartFlow, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01943903 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01943903 about?
NCT01943903 is a clinical study titled "The PLATFORM Study: Prospective LongitudinAl Trial of FFRct: Outcome and Resource IMpacts)". The objective of the PLATFORM Study is to compare clinical outcomes, resource utilization, and quality of life (QOL) of FFRCT-guided evaluation versus standard practice evaluation in patients with suspected CAD in order to further inform patients, health care providers, and other stakeholders about ...
What is the current status of trial NCT01943903?
This trial is currently completed. The enrollment target is 584 participants. The study started on 2013-09. Estimated completion is 2015-12.
Who is sponsoring clinical trial NCT01943903?
This trial is sponsored by HeartFlow, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.